7 articles
Index of editorial tags and filtered coverage.
The UK government announced on October 12, 2026, a package to strengthen national defenses against risks from increasingly powerful AI, including an extension of a frontier-AI cyber defense program that it says has already helped find and fix more than 1,000 vulnerabilities across government systems.
In early October 2026, the Chips Joint Undertaking opened two calls worth €80 million: €10 million for AI-chip demonstrators already taped out, and €70 million for a shared evaluation platform and pilot procurement path. Both close on 27 October 2026 at 5 p.m. Brussels time.
After the House’s 417–3 vote on 16 September 2026 for H.R. 9340 (the Ratepayer Protection Act)—directing state commissions to consider making data centres over 100 MW pay their incremental grid costs—30 September coverage puts the procedural fight in the Senate. Guthrie, Latta and Evans sell it as consumer armour that still lets the AI race run.
In late September 2026 Oracle sent a force majeure notice to a Blue Owl/STACK Infrastructure subsidiary on Project Jupiter in Doña Ana County, New Mexico, citing power delays, air-quality permits for the microgrid and a gas pipeline. Reuters, Bloomberg and local press report Oracle is protecting contractual rights against a ~2028 operational target, without abandoning the project.
On September 14, 2026, Forbes and RuntimeWire covered Cognichip’s enterprise launch of Artificial Chip Intelligence (ACI), founded by Faraj Aalaei. The system uses native physics-informed models—not LLM wrappers—for microarchitecture, RTL, verification and PPA; one cited case compressed a 55-page spec into days versus 4–5 months. Public evidence remains company and customer benchmarks.
Semiconductor Report in September 2026 describes how AI demand is tightening DRAM/NAND/HBM, PMICs, controllers, and PCB FR-4 materials: PMIC lead times from 6–8 to 12–16 weeks; some suppliers stop taking new orders; copper foil prioritized for high-frequency laminates; FR-4 lead times from 2 to 4–6 weeks. Tightness may persist into 2027.
Startups and pharmas integrated generative and predictive models into molecular design, with early clinical candidates.